HPLC Guard Columns and Cartridges
Sepax Technologies Inc Sepax HPLC Column HPLC GUARD Column, BioMix SEC-300, 3 µm, 4.6 x 50 mm
Utilizing proprietary surface technologies and 3 µm particle size, BioMix-300 phase is made of uniform, hydrophilic, and neutral nanometer thick films chemically bonded on the high purity and enhanced mechanical stability silica. The proprietary surface technologies allow the chemistry of thin film formation to be well controlled, which results in high column-to-column reproducibility. The nature of the chemical bonding and the uniformity of the thin film benefit BioMix-300 phase with high stability. BioMix-300 resin is produced from 3 µm spherical silica particles with a pore size of 300 Å. BioMix-300 columns are packed with a proprietary slurry technique to achieve uniform and stable packing bed density for maximum column efficiency. BioMix-300 phase is designed to ensure highest resolution and maximum recovery for a broad range of analytes such as bispecific mAb, hydrophobic samples etc.
Sepax Technologies Inc Sepax HPLC Column Bio-C4, 3 µm, 300 Å, 4 x 10 mm
Monomeric and fully endcapped Bio-C4 packing is bonded with butyl groups that lead to moderate hydrophobicity. Bio-C4 packings of 300 Å pore size selection are ideal for high resolution mapping of peptides and separation of intact proteins, and natural and synthetic peptides.
Sepax Technologies Inc Sepax HPLC Column GP-C8, Guard cartridge with holder, 3 µm, 120 Å, 2 x 10 mm
GP-C8 phase is synthesized with monomeric and fully endcapped chemistry. The uniform octyl stationary phase allows high efficiency with lower hydrophobicity compared to ODS phase. GP-C8 phase is suitable for separating compounds with a wide range of hydrophobicity. It is highly recommended for separating the compounds which are too strongly retained on C18 phases.
Sepax Technologies Inc Sepax HPLC Column Proteomix WCX, NP3, 4 x 10 mm
Proteomix ion-exchange phases have been innovatively developed for achieving high ion-exchange capacity, a breakthrough technology for non-porous resins. Proteomix packing support is composed of a rigid, spherical, highly cross-linked poly(styrene divinylbenzene) (PS/DVB) non-porous bead with particle size selections of 1.7, 3, 5 and 10 µm. The PS/DVB resin surface is grafted with a highly hydrophilic, neutral polymer thin layer with the thickness in the range of nanometer. The hydrophobic PS/DVB resin surface is totally covered by a hydrophilic coating that eliminates non-specific bindings with biological analytes, leading to high efficiency and high recovery separations for biological molecules.
Sepax Technologies Inc Sepax HPLC Column BR-C18, Guard cartridge with holder, 3 µm, 120 Å, 4 x 10 mm
Utilizing highest purity and enhanced mechanical stability silica and pure bonding reagents, BR-C18 bonded phases have been innovatively and specially designed to ensure maximum surface coverage and full end-capping, which leads to carbon content as high as 19.0%. The bonding chemistry is completely controlled that results in very reliable column-to-column reproducibility. The maximum surface coverage allows BR-C18 to have exceptional stability, resulting in high pH stability in the range of 1.5 to 10.5.
Optimize Technologies OPTI-LYNX™ Guard Column Cartridge, 3mm x 15mm, C8, 5pk
OPTI-LYNX Guard Column Cartridge, 3mm x 15mm, C8, 5/Pk
Sepax Technologies Inc Sepax HPLC Column HP-Silica, 5 µm, 120 Å, 2 x 10 mm
HP-Silica phase is made of activated hydroxyl (-OH) functional group with the pore size selection of 120 Å and particle size selection of 1.8, 3, 5, and 10 µm. Carbon loading is 0.0%. HP-Silica is used as the normal phase as well as HILIC phase. HP-Silica phases are suitable for separations of polar and basic organic compounds, such as vitamins, steroids, as well as pharmaceuticals.
Sepax Technologies Inc Sepax HPLC Column GP-C8, 3 µm, 120 Å, 2 x 10 mm
GP-C8 phase is synthesized with monomeric and fully endcapped chemistry. The uniform octyl stationary phase allows high efficiency with lower hydrophobicity compared to ODS phase. GP-C8 phase is suitable for separating compounds with a wide range of hydrophobicity. It is highly recommended for separating the compounds which are too strongly retained on C18 phases.
Optimize Technologies OPTI-LYNX™ Guard Column Cartridge, 3mm x 15mm, Cyano (CN), 5pk
OPTI-LYNX Guard Column Cartridge, 3mm x 15mm, Cyano (CN), 5/Pk
Optimize Technologies OPTI-LYNX™ Guard Column Cartridge, 3mm x 15mm, Cation Exchange (SCX), 5pk
OPTI-LYNX Guard Column Cartridge, 3mm x 15mm, Cation Exchange (SCX), 5/Pk
Optimize Technologies OPTI-LYNX™ Guard Column Cartridge, 3mm x 15mm, Silica
OPTI-LYNX Guard Column Cartridge, 3mm x 15mm, Silica
Sepax Technologies Inc Sepax HPLC Column GP-C4, 3 µm, 120 Å, 4 x 10 mm
Monomeric and fully endcapped GP-C4 packing is bonded with butyl groups that lead to moderate hydrophobicity. GP-C4 columns have unique selectivity and peak symmetry with moderate retention for separations of acidic, neutral and basic organic compounds, such as pharmaceuticals, peptides, and organic acids.
Sepax Technologies Inc Sepax HPLC Column Proteomix SAX, NP1.7, Guard cartridge with holder, 2 x 10 mm
Sepax HPLC Column Proteomix SAX, NP1.7, Guard cartridge with holder, 2 x 10 mm
WELCH MATERIALS INC Ultisil XB-C18, Semi-Prep Cartridge: 5µm, 120Å, 10×10mm
Welch preparative guard column cartridges use the same packing as the preparative column, which can intercept some of the same polar substances in the sample and prevent them from contaminating and damaging the packing materials in the preparative column. 10×10mm cartridge holder: 00808-01116, 21.2×10mm cartridge holder: 00808-01106, 30×10mm cartridge holder: 00808-01117, 50×10mm cartridge holder: 00808-01110.Ultisil XB-C18 is one of the most versatile C18 analytical columns on the market. It features advanced bonding and double-endcapping technology, delivering nearly perfect peak shapes. This column is ideal for analyzing complex matrix samples and provides excellent peak shapes for acidic and basic compounds. It is particularly effective for the separation of traditional Chinese medicine compounds.